|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Central Nervous System Neoplasms | |||||
| Glioblastoma | |||||
| Nervous System Neoplasms | |||||
| 2 | More general conditions related to this trial | ||||
| Astrocytoma | |||||
| Glioma | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms by Site | |||||
| Neoplasms, Germ Cell and Embryonal | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Neoplasms, Nerve Tissue | |||||
| Neoplasms, Neuroepithelial | |||||
| Nervous System Diseases | |||||
| Neuroectodermal Tumors | |||||
| 3 | Interventions listed in this trial | ||||
| adjuvant therapy | |||||
| conventional surgery | |||||
| fluorescence in situ hybridization | |||||
| immunologic technique | |||||
| laboratory biomarker analysis | |||||
| needle biopsy | |||||
| neoadjuvant therapy | |||||
| 4 | Sponsors listed in this trial | ||||
| Mayo Clinic | |||||
| National Cancer Institute (NCI) | |||||